G266-1393 Screening compound: methyl 3-({[1,3-dimethyl-6-(morpholin-4-yl)-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]carbamoyl}amino)benzoate

G266-1393 Screening compound: methyl 3-({[1,3-dimethyl-6-(morpholin-4-yl)-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]carbamoyl}amino)benzoate
G266-1393 Screening compound: methyl 3-({[1,3-dimethyl-6-(morpholin-4-yl)-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]carbamoyl}amino)benzoate alternative view

Chemical Structure Depiction of ChemDiv screening compound G266-1393
methyl 3-({[1,3-dimethyl-6-(morpholin-4-yl)-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]carbamoyl}amino)benzoate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G266-1393

Molecular Formula

C22H25N5O5 (C22 H25 N5 O5)

Compound Name

methyl 3-({[1,3-dimethyl-6-(morpholin-4-yl)-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]carbamoyl}amino)benzoate

IUPAC name

methyl 3-({[13-dimethyl-6-(morpholin-4-yl)-2-oxo-23-dihydro-1H-13-benzodiazol-5-yl]carbamoyl}amino)benzoate

SMILES

CN(c(cc(c(N1CCOCC1)c1)NC(Nc2cc(C(OC)=O)ccc2)=O)c1N1C)C1=O

InChI

InChI=1S/C22H25N5O5/c1-25-18-12-16(24-21(29)23-15-6-4-5-14(11-15)20(28)31-3)17(27-7-9-32-10-8-27)13-19(18)26(2)22(25)30/h4-6,11-13H,7-10H2,1-3H3,(H2,23,24,29)

InChI Key

RKDSYOARXDEMCN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27212069

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

439.47

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

3.443

Distribution Coefficient, logD

3.440

Water Solubility, LogSw

-3.73

Polar Surface Area

81.762

Acid Dissociation Constant (pKa)

9.56

Base Dissociation Constant (pKb)

4.39

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

31.80

G266-1393 in Drug Discovery

Included in Screening Libraries

PI3K-Targeted Library (17255 compounds)

SH2 Library (10483 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Endocrine
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases
  • Kinases
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with G266-1393 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G266-1393?
Check Price and Availability of G266-1393, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G266-1393 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G266-1393
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G266-1393
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G266-1393 available by request